Table 1 Clinical details of the patients
Case | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
|---|---|---|---|---|---|---|---|---|---|
Age | 3 d | 5 d | 8 d | 2 mo | 10 mo | 12 mo | 5 mo | 40 mo | 36 mo |
Sex | F | M | M | M | F | M | F | F | M |
Weight (kg) | 2.1 | 2.1 | 2.5 | 2.6 | 5.3 | 5.8 | 7.2 | 12 | 13 |
Underlying disease | AS | CoA/C | CoA/C | TGA | TA | Hypo RV ASD VSD | (−) | (−) | (−) |
Cause of ICU admissions | CS | CS | CS | DS | DS | CS | CS | HSES | HSES |
Infection | (−) | (−) | (−) | (+) | (+) | (−) | (−) | (+) | (+) |
FFP administration (ml) | 120 | 120 | 120 | 120 | 240 | 240 | 480 | 720 | 720 |
QB (ml/min) | 12 | 12 | 10 | 12 | 30 | 25 | 20 | 40 | 40 |
QD (ml/h) | 500 | 500 | 500 | 500 | 1000 | 1000 | 1500 | 2000 | 2000 |
Hemofilter | UT300S | UT300S | UT300S | UT300S | UT300S | UT300S | UT300S | UT700S | UT700S |
Duration of PHDF (h) | 5 | 5 | 5.5 | 5 | 5 | 4 | 5 | 4.5 | 4 |
Duration of CHDF (h) | 935 | 56 | 664 | 280 | 744 | 86 | 61 | 589 | 132 |
PELOD-2 score at day 0 | 22 | 14 | 23 | 16 | 14 | 20 | 21 | 20 | 17 |
PMR by PELOD-2 score | 0.98 | 0.49 | 0.98 | 0.71 | 0.49 | 0.94 | 0.96 | 0.94 | 0.80 |
28-day outcome(the day of death) | Survival | Survival | Survival | Survival | Survival | Death (4) | Death (3) | Survival | Survival |